رابطه راهبری شرکتی و مخارج تحقیق و توسعه شرکت‌های دارویی پذیرفته شده در بورس اوراق بهادار تهران

1      Gillan, S. L. and L. T. Starks (2003). “Corporate Governance, Corporate Ownership, and the Role of Institutional Investors: A Global Perspective”, Journal of Applied Finance, Vol. 13, No. 2, pp. 4-22.

2      Salehi, M. and F. Davtalabe Tousi (2015). “Investigating the Effect of Ownership Structure on the Firm Value of Pharmaceutical Companies Listed on the Tehran Stock Exchange through Panel Data Analysis”, Journal of Health Accounting, Vol. 3, No. 3, pp. 79-100. [In Persian]

3      Baysinger, B. D.; Kosnik, R. D.; and T. A. Turk (1991). “Effects of Board and Ownership Structure on Corporate R&D Strategy”, The Academy of Management Journal, Vol. 34, No. 1, pp. 205-214.

4      Baradran Hassanzadeh, R.; Badavar Nahandi, Y.; and G. Babaei (2012). “Investigating the Relationship between Some Corporate Governance Mechanisms with the Value Created for Shareholders and Economic Value Added”, The Iranian Accounting and Auditing Review, Vol. 19, No. 2, pp. 1-16. [In Persian]

5      Baysinger, B. and R. E. Hoskisson (1990). “The Composition of Boards of Directors and Strategic Control: Effects on Corporate Strategy”, The Academy of Management Review, Vol. 15, No. 1, pp. 72-87.

6      Namazi, M. and A. Shokrollahi (2015). “Investigating the Interaction between Debt Policy and Institutional Ownership among Pharmaceutical and Non-Pharmaceutical Companies Listed on the Tehran Stock Exchange through Simultaneous Equations”, Journal of Health Accounting, Vol. 3, No. 4, pp. 80-103. [In Persian]

7      Namazi, M. and E. Kermani (2008). “Investigating the Effects of Ownership Structure on the Performance of the Companies Listed on the Tehran Stock Exchange”, Iranian Accounting and Auditing Review, Vol. 15, No. 53, pp. 83-100. [In Persian]

8      Tribo, J. A.; Berrone, P.; and J. Surroca (2007). “Do the Type and Number of Blockholders Influence R&D Investments? New Evidence from Spain”, Corporate Governance, Vol. 15, No. 5, pp. 828-842.

9      Lee, M. (2015). “Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea”, Osong Public Health and Research Perspectives, Vol. 6, No. 4, pp. 249-255.

10  Chan, L. K.; Lakonishok, J.; and T. Sougiannis (2001). “The Stock Market Valuation of Research and Development Expenditures”, The Journal of Finance, Vol. 56, No. 6, pp. 2431-2456.

11  David, P.; Hitt, M. A.; and J. Gimeno (2001). “The Influence of Activism by Institutional Investors on R&D”, Academy of Management Journal, Vol. 44, No. 1, pp. 144-157.

12  Honoré, F.; Munari, F.; and B. Van Pottelsberghe De La Potterie (2011). “Corporate Governance Practices and Companies’ R&D Orientation: Evidence from European Countries”, Bruegel Working Paper, Available at: http://hdl.handle.net/10419/780 10.[Online] [8 November 2016] 

13  DiMasi, J. A.; Grabowski, H. G.; and R. W.  Hansen (2016). “Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs”, Journal of Health Economics, Vol. 47, pp. 20-33.

14  Cherensky, S. S. (1994). “Shareholders, Managers, and Corporate R&D Spending: An Agency Cost Model”, Computer & High Technology Law Journal, Vol. 10, No. 2, pp. 299-346.

15  Mehrabanpour, M.; Kazempour, M.; and F. Esmaeil Beigi (2017). “Defining the Mutual Relationship between Social Responsibility and Corporate Governance by Using Simultaneous Equations”, Journal of Health Accounting, Vol. 5, No. 2, pp. 112-129. [In Persian]

16  Tariverdi, Y.; Emami, A.; and H. Badi'i (2016). “The Impact of Corporate Governance on Accounting Conservatism”, Economic Journal, Vol. 16, Nos. 7 and 8, pp. 79-92. [In Persian]

17  Farzinvash, A.; Dadgar, Y.; Mehrara, M.; and A. Najarzadeh (2017). “The Role of Corporate Governance in Banking Sector Perfomance Indices”, Journal of Economic Research and Policies, Vol. 25, No. 82, pp. 261-310. [In Persian]

18  Audit Organization (2016). Accounting Standards, 27^th Edition, Tehran: Audit Organization. [In Persian]

19  Azar, A.; Jokar, S.; and A. Zangouei Nezhad (2010). “Devising Research and Development Strategy Using Technology Quality Function Deployment: Market Pull Approach”, Industrial Management, Vol. 2, No. 4, pp. 3-18. [In Persian]

20  Hosono, K.; Tomiyama, M.; and T. Miyagawa (2004). “Corporate Governance and Research and Development: Evidence from Japan”, Economics of Innovation and New Technology, Vol. 13, No. 2, pp. 141-164.

21  Khanchel, I. (2007). “Corporate Governance: Measurement and Determinant Analysis”, Managerial Auditing Journal, Vol. 22, No. 8, pp. 740-760.

22  Khodadadi, V.; Nikkar, J.; and S. Veisi (2017). The Effect of Corporate Governance Criteria on Timliness of Financial Reporting Disclosures”, Empirical Studies in Financial Accounting, Vol. 13, No. 52, pp. 61-82. [In Persian]

23  Namazi, M. and M. Ebrahimi Maimand (2016). “Investigating the Effect of Corporate Governance Strategies on Risks Disclosure”, Financial Accounting Journal, Vol. 8, No. 30, pp. 1-39. [In Persian]

24  Jung, K. and S. Y. Kwon (2002). “Ownership Structure and Earnings Informativeness: Evidence from Korea”, The International Journal of Accounting, Vol. 37, No. 3, pp. 301-325.

25  Agahi Oskooee, A. and M. Maleki (2015). “Investigating the Relationship between Corporate Governance and Economic Value Added in Manufacturing Comapines  Listed on the Tehran Stock Exchange”, Asset Management and Financing, Vol. 2, No. 4, pp. 75-96. [In Persian]

26  Belloc, F. (2012). “Corporate Governance and Innovation: A Survey”, Journal of Economic Surveys, Vol. 26, No. 5, pp. 835-864.

27   Bushee, B. J. (1998). “The Influence of Institutional Investors on Myopic R&D Investment Behavior”, The Accounting Review, Vol. 73, No. 3, pp. 305-333.

28  Kochhar, R. and P. David (1996). “Institutional Investors and Firm Innovation: A Test of Competing Hypotheses”, Strategic Management Journal, Vol. 17, No. 1, pp. 73-84.

29  Lee, P. M. and H. M. O'Neill (2003). “Ownership Structures and R&D Investments of U.S. and Japanese Firms: Agency and Stewardship Perspectives”, The Academy of Management Journal, Vol. 46, No. 2, pp. 212-225.

30  Hansen, G. S. and C. W. Hill (1991). “Are Institutional Investors Myopic? A Time-Series Study of Four Technology-Driven Industries”, Strategic Management Journal, Vol. 12, No. 1, pp. 1-16.

31  Banimahd, B.; Arabi, M.; and S. Hassanpour (2016). Empirical Researches and Methodology in Accounting, Edition 2^nd, Tehran: Termeh. [In Persian]